The measured color depends on the activity of mitochondrial and other cellular oxidoreductase enzymes that reduce MTT to formazan. Consequently, the absorbance reflects the cells’ reducing activity at the time of measurement, not simply their number. Changes in enzyme activity or cellular metabolism can therefore alter the signal even when cell loss has not occurred.
Metabolic activity may change before cells die or may shift because cells alter their function in response to an experimental condition. A lower absorbance can therefore indicate reduced cellular metabolic activity without proving irreversible neuronal loss. In neuroscience experiments, interpreting the assay alongside complementary viability or cell-function measurements helps distinguish metabolic suppression from actual changes in survival.
The purple formazan product represents the accumulated result of cellular reduction of MTT. Its amount is quantified after the insoluble product has been dissolved and measured by absorbance. The signal provides an estimate of overall metabolic activity in the tested sample, so differences between conditions should be interpreted as changes in reduction capacity rather than as an exclusive count of living cells.
Controls establish the reference absorbance against which treated samples are evaluated and help reveal whether a change reflects altered cellular metabolism or reduced viability. They are especially important when treatments may affect oxidoreductase activity independently of cell number. Including appropriate controls, together with complementary assays, strengthens conclusions about neuronal injury, protection, or functional change.
A typical workflow exposes cells to the experimental conditions, adds the MTT reagent, and permits viable cells to generate insoluble formazan. The product is then dissolved, and its absorbance is quantified with a microplate reader. Comparing these readings with suitable controls provides an estimate of treatment-associated changes in cellular metabolic activity.
Neuroscience researchers can apply the assay to examine neuronal survival, glial responses, neurotoxicity, and the protective effects of experimental treatments. For example, differences in absorbance between treated and control cell populations can indicate whether a condition is associated with reduced or preserved metabolic activity. The assay therefore supports screening and comparative evaluation of cellular responses.
A changed absorbance indicates that the treatment affected the sample’s cellular reduction activity, but the direction and magnitude should not be treated as a definitive measure of cell death or protection by themselves. Interpretation requires comparison with controls and, when distinguishing survival from altered function matters, complementary assays that assess the relevant biological outcome directly.